Evidence map›Paper›PMID 33375144›Full record

ReviewHealthcare (Basel, Switzerland)2020

The Possible Relationship between the Abuse of Tobacco, Opioid, or Alcohol with COVID-19.

Yusuf S Althobaiti, Maram A Alzahrani, Norah A Alsharif, Nawal S Alrobaie, Hashem O Alsaab, Mohammad N Uddin

Open access · goldAbstract readReview
In one paragraph

Review in Healthcare (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Opioid usage and COVID-19 prognosis: A systematic review and meta-analysis.The American journal of emergency medicine · 2022
    Pooled it
  2. Review
  3. Blood ACE2 Protein Level Correlates with COVID-19 Severity.International journal of molecular sciences · 2023
    Article
  4. Substances of abuse and their effect on SAR-CoV-2 pathogenesis.NeuroImmune pharmacology and therapeutics · 2023
    Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Gender and genetic factors impacting COVID-19 severity.Journal of family medicine and primary care · 2021
    Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yusuf S AlthobaitiAddiction and Neuroscience Research Unit, Health Science Campus, Taif University, Taif 21974, Saudi Arabia.ORCID 0000-0003-3128-2824
Maram A AlzahraniAddiction and Neuroscience Research Unit, Health Science Campus, Taif University, Taif 21974, Saudi Arabia.
Norah A AlsharifAddiction and Neuroscience Research Unit, Health Science Campus, Taif University, Taif 21974, Saudi Arabia.
Nawal S AlrobaieAddiction and Neuroscience Research Unit, Health Science Campus, Taif University, Taif 21974, Saudi Arabia.
Hashem O AlsaabDepartment of Pharmaceutics and Pharmaceutical Technology, Taif University, Taif 21944, Saudi Arabia.
Mohammad N UddinCollege of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
Taif University · SAMercer University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alcoholCOVID-19opioidssmokingsubstance use disorder

Identifiers

PMID33375144
PMCPMC7822153
OpenAlexW3114697333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.